< Terug naar vorige pagina


Tofacitinib in Pregnancy: Assessing Pregnancy and Infant Outcomes, Cord Blood, and Breast Milk Concentrations.

Tijdschriftbijdrage - e-publicatie

Janus kinase (JAK) inhibitors are effective anti-inflammatory agents for treatment of ulcerative colitis (UC).1 According to drug regulatory agencies and international guidelines, JAK inhibitors should be avoided during pregnancy and lactation.2-4 The existing evidence on safety of JAK inhibitors during pregnancy is scarce and almost exclusively limited to tofacitinib.4-7.
Tijdschrift: Clinical Gastroenterology and Hepatology
ISSN: 1542-3565
Pagina's: S1542-3565
Jaar van publicatie:2024